ROXITHROMYCIN: 352 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
352
Total FAERS Reports
43 (12.2%)
Deaths Reported
189
Hospitalizations
352
As Primary/Secondary Suspect
24
Life-Threatening
7
Disabilities
First Report: 199504 · Latest Report: 20250619
What Are the Most Common ROXITHROMYCIN Side Effects?
#1 Most Reported
Diarrhoea
30 reports (8.5%)
#2 Most Reported
Nausea
28 reports (8.0%)
#3 Most Reported
Erythema
26 reports (7.4%)
All ROXITHROMYCIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 30 | 8.5% | 0 | 13 |
| Nausea | 28 | 8.0% | 0 | 12 |
| Erythema | 26 | 7.4% | 0 | 14 |
| Arthralgia | 24 | 6.8% | 0 | 9 |
| Bladder transitional cell carcinoma | 23 | 6.5% | 0 | 23 |
| Headache | 20 | 5.7% | 0 | 16 |
| Jaundice | 18 | 5.1% | 0 | 16 |
| Palpitations | 18 | 5.1% | 0 | 5 |
| Abdominal pain upper | 17 | 4.8% | 0 | 2 |
| Asthenia | 17 | 4.8% | 0 | 7 |
| Vomiting | 17 | 4.8% | 0 | 14 |
| Arrhythmia | 16 | 4.6% | 0 | 1 |
| Drug reaction with eosinophilia and systemic symptoms | 16 | 4.6% | 0 | 16 |
| Gait disturbance | 14 | 4.0% | 0 | 14 |
| Hepatitis | 14 | 4.0% | 0 | 9 |
| Myocardial infarction | 14 | 4.0% | 14 | 0 |
| Toxicity to various agents | 14 | 4.0% | 5 | 6 |
| Agranulocytosis | 13 | 3.7% | 0 | 2 |
| Cardiovascular disorder | 13 | 3.7% | 0 | 0 |
| Drug-induced liver injury | 13 | 3.7% | 0 | 10 |
Who Reports ROXITHROMYCIN Side Effects? Age & Gender Data
Gender: 57.9% female, 42.1% male. Average age: 57.9 years. Most reports from: FR. View detailed demographics →
Is ROXITHROMYCIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 10 | 0 | 10 |
| 2002 | 2 | 0 | 0 |
| 2004 | 5 | 4 | 5 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2012 | 3 | 0 | 3 |
| 2013 | 6 | 0 | 3 |
| 2014 | 10 | 4 | 4 |
| 2015 | 12 | 0 | 9 |
| 2016 | 13 | 0 | 7 |
| 2017 | 38 | 9 | 29 |
| 2018 | 26 | 0 | 21 |
| 2019 | 25 | 0 | 15 |
| 2020 | 37 | 5 | 13 |
| 2021 | 2 | 2 | 0 |
| 2022 | 3 | 0 | 2 |
| 2023 | 38 | 12 | 4 |
| 2024 | 19 | 0 | 17 |
| 2025 | 4 | 0 | 1 |
What Is ROXITHROMYCIN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 139 |
| Lung disorder | 25 |
| Bronchitis | 17 |
| Ear, nose and throat infection | 13 |
| Pneumonia | 13 |
| Rhinitis | 13 |
| Infection | 11 |
| Nasopharyngitis | 8 |
| Upper respiratory tract infection | 8 |
| Hidradenitis | 6 |
ROXITHROMYCIN vs Alternatives: Which Is Safer?
ROXITHROMYCIN vs ROZANOLIXIZUMAB
ROXITHROMYCIN vs ROZANOLIXIZUMAB-NOLI
ROXITHROMYCIN vs RUBIDIUM RB-82
ROXITHROMYCIN vs RUCAPARIB
ROXITHROMYCIN vs RUCAPARIB CAMSYLATE
ROXITHROMYCIN vs RUFINAMIDE
ROXITHROMYCIN vs RUPATADINE
ROXITHROMYCIN vs RUXOLITINIB
ROXITHROMYCIN vs SABRIL
ROXITHROMYCIN vs SACCHAROMYCES CEREVISIAE
Official FDA Label for ROXITHROMYCIN
Official prescribing information from the FDA-approved drug label.